All broker reports have PLS rated well above current price, with as far as I can see, the lowest being Macquaries's (low) valuation of 64c.
These valuations were formed knowing the ROFR deal with GAM, and before any of the recent offtakes/ resource upgrade news.
Stock is seriously undervalued.
This is not intended to ramp, but to calm the nerves of the newer/ more nervous shareholders.
- Forums
- ASX - By Stock
- PLS
- Undervalued according to all broker reports
Undervalued according to all broker reports
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.06 |
Change
0.040(1.32%) |
Mkt cap ! $9.316B |
Open | High | Low | Value | Volume |
$3.04 | $3.12 | $3.02 | $47.83M | 15.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 341990 | $3.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 276819 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34457 | 3.330 |
1 | 78700 | 3.310 |
1 | 4532 | 3.300 |
1 | 6872 | 3.270 |
8 | 560782 | 3.230 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 93476 | 2 |
2.830 | 33368 | 1 |
2.900 | 9386 | 2 |
2.910 | 493203 | 18 |
2.920 | 95887 | 8 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
PLS (ASX) Chart |